Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysis

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers (ARBs) have been hypothesized to benefit patients with COVID-19 via the inhibition of viral entry and other mechanisms. We conducted an individual participant data (IPD) meta-analysis assessing the effect of starting the A...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Stefano, Leon, Ram, Malathi, Scharfstein, Daniel O., Li, Tianjing, Khanal, Preeti, Baksh, Sheriza N., McBee, Nichol, Bengtson, Charles D., Gadomski, Anne, Geriak, Matthew, Puskarich, Michael A., Salathe, Matthias A., Schutte, Aletta E., Tignanelli, Christopher J., Victory, Jennifer, Bierer, Barbara E., Hanley, Daniel F., Freilich, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256351/
https://www.ncbi.nlm.nih.gov/pubmed/37335665
http://dx.doi.org/10.1097/MD.0000000000033904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256351/
https://www.ncbi.nlm.nih.gov/pubmed/37335665
http://dx.doi.org/10.1097/MD.0000000000033904

Ejemplares similares